Noah S. Kalman, MD, MBA, discusses the evolving role of molecular and genetic testing in thyroid cancer management.

Background: High-risk differentiated thyroid cancer in 2015 American Thyroid Association risk stratification system (ATA-RSS) exhibits a significantly increased probability of recurrence and poor ...

Recurrent laryngeal injury risk was reduced with intraoperative nerve monitoring among patients with thyroid cancer undergoing thyroidectomy.

A commentary in the Journal of Family Medicine and Primary Care advises primary care clinicians on how to manage patients ...

Follicular thyroid cancer with bone involvement was associated with a significantly elevated risk for brain metastases among women.

Exposure to high-normal, compared with low-normal, TSH levels was not associated with an elevated risk for differentiated thyroid cancer recurrence after thyroidectomy. Exposure to high-normal ...

Thyroid cancer is cancer of the thyroid gland in the neck. Thyroid cancer affects women more often than men. It has a good prognosis. Risk factors include a family history of this cancer, radiation ...

Thyroid cancer is typically first noticed as a thyroid nodule. The symptoms may be the same for both, but females are more likely to get thyroid cancer than men. (Photo Credit: Sebastian Kaulitzki ...

Background: Follicular thyroid cancer (FTC) is the second most common malignancy of thyroid. About 7%–23% of patients with FTC have distant metastasis. The aim of this study was to investigate the ...

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

Patients with low-risk differentiated thyroid cancer show similar outcomes after 5 years regardless of whether they received radioactive iodine following total thyroidectomy, results from a ...